C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1994
11/15/1994	US5364762 Major histocompatibility complex (MHC) molecules
11/15/1994	US5364761 Method for isolating a DNA encoding an autonomously replicating sequence
11/15/1994	US5364757 Methods of supporting a diagnosis of systemic lupus erythematosus
11/15/1994	US5364624 Inhibitors of human leukocyte elastase, treatment of cystic fibrosis
11/15/1994	US5364619 Oncoimmunins
11/15/1994	CA2123364A1 Process for purification of water soluble penicillin binding protein 2a
11/12/1994	CA2123252A1 Polypeptide and dnas encoding it
11/12/1994	CA2123251A1 Polypeptide and dnas encoding it
11/12/1994	CA2123250A1 Polypeptide and dnas encoding it
11/12/1994	CA2123249A1 Polypeptide and dnas encoding it
11/12/1994	CA2122937A1 Human chondromodulin-i protein
11/11/1994	CA2123144A1 Stabilisation of pharmacologically active compounds in sustained release compositions
11/10/1994	WO1994025874A1 Diagnostic kit and method for the simultaneous diagnosis of hepatitis b and c
11/10/1994	WO1994025872A1 Cell test for alzheimer's disease
11/10/1994	WO1994025625A1 Means for detecting familial colon cancer (fcc)
11/10/1994	WO1994025616A1 Cell-targeted lytic pore-forming agents
11/10/1994	WO1994025613A1 Isolated dna elements that direct pistil-specific and anther-specific gene expression and methods of using same
11/10/1994	WO1994025611A1 Integrative dna segment comprising gene encoding insecticidal protein
11/10/1994	WO1994025610A1 Compositions and methods for immunotherapy with the alpha-3 domain of a class i major histocompatibility molecule
11/10/1994	WO1994025608A1 Natural or recombinant dna binding proteins as carriers for gene transfer or gene therapy
11/10/1994	WO1994025607A1 Method of assaying for drugs which restore function of mutant cftr protein
11/10/1994	WO1994025606A2 Recombinant alanine racemase and gapdh from tolypocladium
11/10/1994	WO1994025602A1 Hepatitis-c virus type 4, 5 and 6
11/10/1994	WO1994025601A2 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
11/10/1994	WO1994025600A1 Recombinant antigens from mumps virus and their use in vaccines
11/10/1994	WO1994025599A1 Mammal cell lines and method of obtaining glycoproteins
11/10/1994	WO1994025598A2 Methods and compositions for salmonella-based vaccines
11/10/1994	WO1994025597A2 METHODS AND COMPOSITIONS FOR DETECTION OF $i(SALMONELLA)
11/10/1994	WO1994025596A2 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS
11/10/1994	WO1994025595A2 Cytolysin gene and gene product
11/10/1994	WO1994025594A2 Cloning, expression and vaccine composition corresponding to a peptide antigen of toxoplasma gondii
11/10/1994	WO1994025593A2 Method for obtaining male-sterile plants
11/10/1994	WO1994025592A1 A novel gene coding human epidermal growth factor and process for preparing the same
11/10/1994	WO1994025590A2 Trichohyalin and transglutaminase-3 and methods of using same
11/10/1994	WO1994025589A1 Cannabinoid receptor expressed in cells of the immune system
11/10/1994	WO1994025582A1 Method of enhancing thrombolysis
11/10/1994	WO1994025573A1 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies
11/10/1994	WO1994025572A1 Mycobacterial species-specific reporter mycobacteriophages
11/10/1994	WO1994025570A1 Method for screening for targets for anti-inflammatory or anti-allergic agents
11/10/1994	WO1994025491A1 Fibrin-targeted inhibitors of thrombin
11/10/1994	WO1994025489A1 Downregulation of allergen-specific immune response
11/10/1994	WO1994025487A1 A method for rapid formation and isolation of focal adhesion complexes
11/10/1994	WO1994025486A1 Improved hcv diagnostic agents
11/10/1994	WO1994025484A1 Biologically active peptides
11/10/1994	WO1994025483A1 Immunotherapeutic peptides derived from toxic shock syndrome toxin-1, antibodies thereto, their uses in pharmaceutical compositions and diagnosis
11/10/1994	WO1994025482A1 Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
11/10/1994	WO1994025481A1 Method of separating glycosylated and non-glycosylated proteins
11/10/1994	WO1994025480A1 Method of purifying hydrophobic polypeptide
11/10/1994	WO1994025477A2 Novel peptide nucleic acids
11/10/1994	WO1994025476A1 Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof
11/10/1994	WO1994025073A1 Recombinant viruses and their use in gene therapy
11/10/1994	WO1994025067A1 Antibodies to p-selectin and their uses
11/10/1994	WO1994025063A1 Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific t cell populations
11/10/1994	WO1994025060A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
11/10/1994	WO1994025057A1 Kgf receptor-derived antagonists of kgf binding
11/10/1994	WO1994025056A2 Use of platelet-derived growth factor to improve collateral circulation
11/10/1994	WO1994025055A1 Erythropoietin analog compositions and methods
11/10/1994	WO1994025054A1 Recombinant vaccine
11/10/1994	WO1994025053A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
11/10/1994	WO1994025047A1 Inhibition of leukocyte adhesion
11/10/1994	WO1994025043A1 Peptides and compounds that bind to elam-1
11/10/1994	WO1994025000A1 Hookworm anticoagulant
11/10/1994	WO1994024959A1 Method of detecting compounds utilizing chemically modified lambdoid bacteriophage
11/10/1994	WO1994024870A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites
11/10/1994	WO1994024864A1 Methods of preventing viral replication
11/10/1994	WO1994023048A3 Gibbon ape leukemia virus-based retroviral vectors
11/10/1994	WO1994023030A3 Methods and materials relating to the functional domains of dna binding proteins
11/10/1994	WO1994021803A3 Fruit ripening-related tomato dna, dna constructs, cells and plants derived therefrom
11/10/1994	WO1994021800A3 Protein tyrosine phosphatase ptp-s31
11/10/1994	WO1994021796A3 Maize chlorotic dwarf virus and resistance thereto
11/10/1994	WO1994021781A3 Extracellular signal-regulated kinase, sequences, and methods of production and use
11/10/1994	WO1994021675A3 T cell epitopes of ryegrass pollen allergen
11/10/1994	WO1994019475A3 Yeast agglutination genes and yeast containing them
11/10/1994	WO1994017193A3 Chimeric l- and p-selectin by exchange of domains - uses thereof
11/10/1994	WO1994013812A3 Novel entomopoxvirus genes, proteins and methods of use thereof
11/10/1994	WO1994012649A3 Gene therapy for cystic fibrosis
11/10/1994	WO1994003075A3 Morphogen-enriched dietary composition
11/10/1994	DE4315334A1 Serum albumin derivative and process for its preparation
11/10/1994	CA2662090A1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
11/10/1994	CA2162157A1 Polyoxime compounds and their preparation
11/10/1994	CA2162056A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites
11/10/1994	CA2162048A1 Cell test for alzheimer's disease
11/10/1994	CA2161971A1 Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof
11/10/1994	CA2161865A1 Peptides and compounds that bind to elam-1
11/10/1994	CA2161796A1 Hookworm anticoagulant
11/10/1994	CA2161772A1 Fibrin-targeted inhibitors of thrombin
11/10/1994	CA2161679A1 Recombinant virus and their use in genic therapy
11/10/1994	CA2161669A1 Use of platelet-derived growth factor to improve collateral circulation
11/10/1994	CA2161651A1 Erythropoietin analog compositions and methods
11/10/1994	CA2161645A1 Recombinant antigens from mumps virus and their use in vaccines
11/10/1994	CA2161534A1 Immunogenic formulation of ospc antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
11/10/1994	CA2161517A1 Mammalian cell lines and method of obtaining glycoproteins
11/10/1994	CA2161515A1 Method for obtaining male-sterile plants
11/10/1994	CA2161438A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
11/10/1994	CA2161405A1 Methods and compositions for detection of salmonella
11/10/1994	CA2161404A1 Methods and compositions for salmonella-based vaccines
11/10/1994	CA2161316A1 Downregulation of allergen-specific immune response
11/10/1994	CA2161230A1 Novel peptide nucleic acids
11/10/1994	CA2161114A1 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies
11/10/1994	CA2161108A1 Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site

1 ... 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 ... 2916